ESR1 and neoplasm: Some previous analyses report no clear differences in strength of association by tumor characteristics [10-12,16-20], while others suggest the association between MD and breast cancer risk differs by estrogen receptor (ER) status [13-16], invasiveness [15,21], and tumor size [7-9].